Form D · Other Health Care
PENTEC HEALTHCARE INFUSIONS, INC.
Minneapolis, MN · CIK 0001551353
Offering snapshot reported Jun 12, 2012 · SEC filing
- Reported sold
- $98.8M Offering amount: $98.8M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 1, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 12, 2012 | Initial | $98,785,500 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-179589
Source: Form D, filed Jun 12, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carter Balfour | Director |
| Rodney Boone | Director |
| Andrew Carragher | Director |
| Joseph Cosgrove | Director, Executive |
| Tim Kuehl | Director |
| Brian Morfitt | Director |
| Arthur Rea, Jr. | Executive |
| Jason Sondell | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Norwest Equity Partners 80 South 8 Th Street, Suite 3600
Minneapolis, MN, 55402
Minneapolis, MN, 55402